Rethinking How We Track and Treat Cancer

diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13^th • 19 mins listen